Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine in children with autism spectrum disorders
NCT00453180Phase 2Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Mar 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetylcysteine in Autism Spectrum Disorder (ASD), sponsored by Indiana University School of Medicine. Primary endpoints: Clinical Global Impression - Severity at 12 weeks and Clinical Global Impression - Improvement at 12 weeks. Started Mar 2007; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00453180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453180.